Key takeaways GLP-1 is often associated with weight-loss drugs, but this class of medications is named after a hormone that helps increase feelings of fullness and regulate blood sugar levels
Compounded semaglutide can offer an alternative
glucose (2 g kg 1 ) injection, did not influence basal blood glucose levels but markedly attenuated rises in blood glucose levels at 15, 30, and 60 min (Fig
The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study
This article describes GLP-1 peptide characteristics and the mechanisms mediating its known role in increasing insulin, decreasing glucagon, delaying gastric emptying, and promoting satiety
However, further in vitro assays showed a different pharmacological profile, since although the effect on cAMP was notable, we did not observe additional significant effects on -arrestin recruitment activation, therefore providing a similar profile than other non-peptidic agonists like CHU-128 and TT-OAD2